首页> 外文OA文献 >Cost-Minimization Analysis of Direct Cost of Sevelamer Carbonate and Lanthanum Carbonate in the Treatment of Patients with Chronic Kidney Disease Not on Dialysis in Bulgaria

【2h】

Cost-Minimization Analysis of Direct Cost of Sevelamer Carbonate and Lanthanum Carbonate in the Treatment of Patients with Chronic Kidney Disease Not on Dialysis in Bulgaria

机译：保加利亚治疗中未接受透析的慢性肾脏病患者使用司维拉姆碳酸盐和碳酸镧镧的直接费用的费用最小化分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Petrov Martin; Dimitrova Maria; Petrova Guenka;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Keith, M.S.a , Wilson, R.J.b , Preston, P.a , Copley, J.B.a Cost-minimization analysis of lanthanum carbonate versus sevelamer hydrochloride in US patients with end-stage renal disease [J] . KeithM.S., WilsonR.J., PrestonP., Clinical therapeutics . 2014,第9期

机译：Keith，M.S.a，Wilson，R.J.b，Preston，P.a，Copley，J.B.a在美国患有终末期肾脏疾病的患者中，碳酸镧与盐酸司维拉姆的成本最小化分析
2. Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients [J] . Hai V. Nguyen, Saideep Bose, Eric Finkelstein BMC Nephrology . 2016,第1期

机译：司维拉姆相对于碳酸钙在透析前慢性肾脏病患者中治疗高磷酸盐血症的成本效益增加
3. Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in chronic kidney disease before and during dialysis [J] . VegterS., TolleyK., KeithM.S., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2011,第6期

机译：碳酸镧治疗透析前后慢性肾脏病高磷酸盐血症的成本效益
4. Low-cost detection of cardiovascular disease on chronic kidney disease and dialysis patients based on hybrid heterogeneous ECG features including T-wave alternans and heart rate variability [C] . Tsu-Wang Shen, Te-Chao Fang, Yi-Ling Ou, 2010 Computers in Cardiology . 2010

机译：基于混合异质ECG功能（包括T波交替蛋白和心率变异性）的低成本检测慢性肾脏病和透析患者的心血管疾病的方法
5. Components of Oral Health in End-Stage Chronic Kidney Disease Patients Undergoing Chronic Dialysis Treatment [D] . Nenova-Nogalcheva, Anna. 2018

机译：口腔健康组分在接受慢性透析治疗的慢性肾病患者中的口腔健康
6. Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients [O] . Hai V. Nguyen, Saideep Bose, Eric Finkelstein 2016

机译：司维拉姆相对于碳酸钙在透析前慢性肾脏病患者中治疗高磷酸盐血症的成本效益增加
7. PUK24 COST- MINIMIZATION ANALYSIS OF THE DIRECT COSTS OF SEVELAMER CARBONATE AND LANTHANUM CARBONATE IN THE TREATMENT OF CKD-ND PATIENTS [O] . Petrov M.K., Dimitrova M., Petrova G.I. 2014

机译：PUK24成本最小化分析斯维默尔碳酸盐和镧碳酸盐在CKD-ND患者中的直接治疗费用
8. Chronic Kidney Disease (CKD) and Diet: Assessment, Management and Treatment. Treating CKD Patients Who Are Not on Dialysis. An Overview Guide for Dietitians [R] . 2011

机译：慢性肾病（CKD）和饮食：评估，管理和治疗。治疗不进行透析的CKD患者。营养师概述指南

Cost-Minimization Analysis of Direct Cost of Sevelamer Carbonate and Lanthanum Carbonate in the Treatment of Patients with Chronic Kidney Disease Not on Dialysis in Bulgaria

著录项

引文网络

相似文献

相关主题

期刊订阅